PP18 Horizon Scanning For Clinical Biosimilar Medicines: Informing The Lifecycle Of Health Technology Assessment And Market Access von Hussain, Amy, Fairbairn, Ross, Ogunbayo, Dapo

Volltext

Combination therapies for COVID‐19: An overview of the clinical trials landscape von Akinbolade, Sola, Coughlan, Diarmuid, Fairbairn, Ross, McConkey, Glenn, Powell, Helen, Ogunbayo, Dapo, Craig, Dawn

Volltext

OP55 Classification System For Innovative Medicines In The Pipeline: New Or Repurposed? von Ogunbayo, Dapo, Coughlan, Diarmuid, Fairbairn, Ross, Akinbolade, Sola

Volltext

New or repurposed: a novel classification system for the horizon scanning of innovative medicines von Fairbairn, Ross, Akinbolade, Sola, Coughlan, Diarmuid, Ogunbayo, Dapo, Meader, Nick, Craig, Dawn

Volltext

OP283 A Pipeline Analysis Of Advanced Therapy Medicinal Products (ATMPs) In Late-Stage Clinical Development von Woltmann, James, Teague, Rhiannon, Ogunbayo, Dapo, Craig, Dawn

Volltext

Closing the loop between horizon scanning and health technology assessment – an overview of topics submitted for appraisal in England von Khan, Sarah Khalid, Gonzalez-Moral, Sonia G., Lanyi, Kate, Ogunbayo, Dapo, Craig, Dawn

Volltext

OP56 A Life Cycle Approach To Horizon Scanning Outputs - From Signals To Guidelines von Gonzalez Moral, Sonia Garcia, Khan, Sarah Khalid, Lanyi, Katherine, Ogunbayo, Dapo, Craig, Dawn

Volltext

OP484 Analysis Of Horizon Scanning Outputs For The National Institute for Health and Care Excellence Health Technology Assessment Process von Khan, Sarah Khalid, Moral, Sonia Garcia Gonzalez, Ogunbayo, Dapo, Craig, Dawn

Volltext